Insider Trading & Ownership of Rashmi Agarwal

Location
Guilford, CT
Summary
The estimated net worth of Rashmi Agarwal is at least $187,267,747 dollars as of 13 Apr 2023. Rashmi Agarwal is the 10%+ Owner of BioXcel Therapeutics, Inc. and owns shares of BioXcel Therapeutics, Inc. (BTAI) stock worth about $187.27M.
Signature
/s/Rashmi Agarwal
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Rashmi Agarwal and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Rashmi Agarwal has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $187,267,747.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: BioXcel Therapeutics, Inc. ($187,267,747).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Rashmi Agarwal

Insider Transactions Reported by Rashmi Agarwal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .